about
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncologyInhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPKSystematic Analysis Reveals Elongation Factor 2 and α-Enolase as Novel Interaction Partners of AKT2BRAT1 deficiency causes increased glucose metabolism and mitochondrial malfunctionMitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cellsPharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progressionPyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cellsTargeting energy metabolism in brain cancer: review and hypothesisHexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondriaApplications of metabolomics in cancer researchMammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growthUnderstanding the Warburg effect: the metabolic requirements of cell proliferationThe Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesisLinks between metabolism and cancerHexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapyExpression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpretedDichloroacetate (DCA) as a potential metabolic-targeting therapy for cancerAKT/PKB signaling: navigating downstreamCardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancerInsights into the Regulatory Role of Non-coding RNAs in Cancer MetabolismNovel drugs that target the metabolic reprogramming in renal cell cancerClinical significance of T cell metabolic reprogramming in cancerAnticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effectMetabolic, autophagic, and mitophagic activities in cancer initiation and progressionDNA Tumor Viruses and Cell MetabolismMetabolomics in rheumatic diseases: desperately seeking biomarkersThe sweet trap in tumors: aerobic glycolysis and potential targets for therapyStarved and Asphyxiated: How Can CD8(+) T Cells within a Tumor Microenvironment Prevent Tumor ProgressionThe Warburg effect and drug resistanceEnergy disruptors: rising stars in anticancer therapy?Dysregulated metabolism contributes to oncogenesisOvarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reductionSuccinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and EpigeneticsRedox Regulation in Cancer Stem CellsTargeting molecular addictions in cancerThe expanding role of yeast in cancer research and diagnosis: insights into the function of the oncosuppressors p53 and BRCA1/2Metabolic modulation of chromatin: implications for DNA repair and genomic integrityMolecular biology of gliomas: present and future challengesAutophagy: a targetable linchpin of cancer cell metabolismCancer cell metabolism: implications for therapeutic targets
P2860
Q21129303-13E64014-0055-4295-80C6-B8A3E4084C51Q21142775-F548DE8A-E679-44D5-BF4A-1E1F4525D342Q24297375-80439ACA-0156-472B-93A1-CAECAE10C0F3Q24301506-874F1143-ABB2-46FA-B211-F97C2A3C809EQ24311397-A12C46F0-1619-4276-B383-B4E6616415C5Q24314416-9F70689B-0F4C-4E05-BB85-242FACC2D228Q24320179-D8D4B24A-63F1-44B7-A30D-C604C3CEB4AAQ24537119-1DBDB536-A7F7-435A-839D-153C1005DC8BQ24595940-5E32DFD3-9C67-49B0-AC2B-2A6703E7EEDBQ24600728-B97FED94-F7CF-46CE-A0B4-B354C111713FQ24603549-18D5AD9A-218B-408D-859B-3E9E439F2ACAQ24604760-80542F9F-B3A9-43E4-BE4C-B6815955D27EQ24613186-F119803E-0110-4432-971C-CF6B7D2F1A7EQ24626229-F4BA4A59-E604-467F-8F58-0BE461A9223FQ24646296-212AD159-1890-44A1-AAAC-38229839A655Q24652381-167D4F14-A0BC-4C07-8307-24F84E0C9A67Q24652941-0A5DD03E-840E-4A74-A849-C6EDA8C8BE89Q24657857-C9C67D54-F623-49B9-954D-799BEC92CDA8Q24658168-F649B1BE-C5EA-44E7-BCB2-18409958CBFBQ26739857-4BE04401-8543-4A88-AF22-FCE8BBAABBDDQ26740187-81D43DC3-315E-4C40-A9C5-DDEB3C05EB78Q26741974-EEDD528B-AECA-4C1D-A12F-12FFA17A4A1BQ26745461-83B15EA8-E53F-4A29-B656-B347B27889C1Q26745503-CAB8146F-7E14-477B-8EFF-AD26847A9CF1Q26749066-8918D213-5B34-44FF-B3BD-601C8F3A48CBQ26765005-1DA1C13F-6258-4B7C-9DDB-BECF821443F5Q26766079-194DB164-E541-43F1-AEB0-ADBBA0C72073Q26767514-9D07D6DB-406B-4189-A63A-AA706E5033CAQ26770007-8FAA9E1E-451C-4764-8C3B-3F3D1C727624Q26771300-AEAB6DC7-41AE-4F88-82C6-420165DBDB67Q26784630-2EC6055B-90CB-45E0-8025-2424BA758A7FQ26786610-77DFDE98-3B0C-43E7-8E99-2FB9AF9B24A8Q26796203-58E8BF28-E3A4-4AF6-80D0-C36D00CA4CF9Q26798198-BFDD0BFC-465F-4F03-AEEC-ACA2ABA28133Q26829525-44A29EA8-0E54-460C-9900-3268677BF405Q26851138-97602B61-B622-4412-9A0D-DE30F11EC444Q26861294-18069D2D-EA56-4187-97ED-DF80181CCA0DQ27001295-95E9F921-6468-4E33-8AD0-A93D7A689060Q27004020-3A9A453E-597E-43AF-AD0E-9B2820E9CB22Q27013632-DF00CB25-26AE-4608-9565-59959CA3BFBF
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Akt stimulates aerobic glycolysis in cancer cells
@ast
Akt stimulates aerobic glycolysis in cancer cells
@en
type
label
Akt stimulates aerobic glycolysis in cancer cells
@ast
Akt stimulates aerobic glycolysis in cancer cells
@en
prefLabel
Akt stimulates aerobic glycolysis in cancer cells
@ast
Akt stimulates aerobic glycolysis in cancer cells
@en
P2093
P3181
P1433
P1476
Akt stimulates aerobic glycolysis in cancer cells
@en
P2093
Abass Alavi
Craig B Thompson
Daniel E Bauer
David R Plas
Hongming Zhuang
Marian H Harris
Monica Buzzai
Rebecca L Elstrom
Robyn Karnauskas
Ryan M Cinalli
P304
P3181
P356
10.1158/0008-5472.CAN-03-2904
P407
P577
2004-06-01T00:00:00Z